DICER1 and neoplasm: Additionally, as more DICER1 variants are curated, the VCEP can revisit the odds of pathogenicity calculations for various evidence codes such as PP4 tumor phenotype evidence or PP3 and BP4 in silico predictor cutoffs and modify the strength of the evidence codes as appropriate.